EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Benralizumab reduces annual cumulative OCS dose while improving asthma control and quality of life in severe eosinophilic asthma: Real-World Evidence from the AURORA study

Sunday 15 Jun, 18:06 PM - 18:18 PM Glasgow, United Kingdom